Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Xianghong Jin"'
Autor:
Ziping Li, Huiwen He, Fujing Zhang, Haolong Li, Xianghong Jin, Yuhang Song, Shuangjiao Liu, Xuan Wang, Junling Zhuang
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundBroad T cell phenotypic alterations and potential dysfunctions were prominent in COVID-19. There are few and inconclusive data about the role of immune checkpoints for T cell exhaustion/activation during SARS-CoV-2 infection in multiple mye
Externí odkaz:
https://doaj.org/article/c223e4626b6e47bba4ab0554a8367d31
Autor:
Xianghong Jin, Hui Li, Dingding Zhang, Shuangjiao Liu, Yuhang Song, Fujing Zhang, Ziping Li, Junling Zhuang
Publikováno v:
Cancer Medicine, Vol 13, Iss 11, Pp n/a-n/a (2024)
Abstract Background Myc rearrangement (Myc‐R) is a controversial factor linked to adverse outcomes in newly diagnosed multiple myeloma (NDMM). Aims This study aimed to evaluate the impact of Myc‐R on the prognosis of NDMM patients and its role in
Externí odkaz:
https://doaj.org/article/b59d0342242440acae7bd975a9bbdced
Autor:
Xianghong Jin, Xianyong Jiang, Wei Wang, Shuangjiao Liu, Bing Han, Jianhua Han, Junling Zhuang
Publikováno v:
Chronic Diseases and Translational Medicine, Vol 9, Iss 4, Pp 341-344 (2023)
Externí odkaz:
https://doaj.org/article/1262180cd099408287479f55ebf253d7
Publikováno v:
Infectious Diseases & Immunity, Vol 2, Iss 1, Pp 55-57 (2022)
Abstract. The novel coronavirus (SARS-CoV-2) infection has become a heavy burden on global health. Although the coronavirus disease 2019 (COVID-19) may adversely affect multiple organs and systems of infected patients, to the best of our knowledge, t
Externí odkaz:
https://doaj.org/article/831162fcab98489789deeaf5cade4cfd
Autor:
Bin Zhou, Xianghong Jin, Weiwei Jin, Xingzhou Huang, Yanfei Wu, Haiying Li, Weijian Zhu, Xiaoyi Qin, Haige Ye, Shenmeng Gao
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-15 (2020)
Abstract Background Overexpression of Wilms’ tumor-1 (WT1) transcription factor facilitates proliferation in acute myeloid leukemia (AML). However, whether WT1 is enriched in the leukemia-initiating cells (LICs) and leukemia stem cells (LSCs) and f
Externí odkaz:
https://doaj.org/article/ff4e25343cd942d58f18a5559e06c132
Publikováno v:
Infectious Diseases & Immunity. 2:55-57
Publikováno v:
ACS Omega, Vol 9, Iss 21, Pp 22754-22763 (2024)
Externí odkaz:
https://doaj.org/article/83deed1a93fa478a879d770f1632c426
Autor:
Xianghong Jin, Jianhua Du, Fujing Zhang, Hui Li, Shuangjiao Liu, Chen Yang, Miao Chen, Daobin Zhou, Junling Zhuang
Publikováno v:
Blood. 140:12575-12575
Publikováno v:
Leukemia & Lymphoma. 61:641-649
The association between serum albumin level and clinical outcomes has been reported for several hematological malignancies. Our study aimed to identify the relationship between serum albumin level ...
Autor:
Haige Ye, Bin Zhou, Shenmeng Gao, Xianghong Jin, Yanfei Wu, Haiying Li, Weijian Zhu, Weiwei Jin, Xiaoyi Qin, Xingzhou Huang
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-15 (2020)
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-15 (2020)
Background Overexpression of Wilms’ tumor-1 (WT1) transcription factor facilitates proliferation in acute myeloid leukemia (AML). However, whether WT1 is enriched in the leukemia-initiating cells (LICs) and leukemia stem cells (LSCs) and facilitate